Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Saved in:
| Title: | Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. |
|---|---|
| Authors: | Bachert C; Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Münster, Münster, Germany.; First Affiliated Hospital, Sun Yat-Sen University, International Airway Research Center, Guangzhou, China.; Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium., Laidlaw TM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Cho SH; Division of Allergy-Immunology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Mullol J; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain., Swanson BN; College of Life Sciences, Thomas Jefferson University, Philadelphia, PA, USA.; Research and Development, Sanofi, Bridgewater, NJ, USA., Naimi S; Molecular and Digital Histopathology, Sanofi, Vitry-sur-Seine, France., Classe M; Pathology Department, Institut Gustave Roussy, Villejuif, France.; Translational Sciences, Sanofi, Chilly-Mazarin, France., Harel S; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Jagerschmidt A; Global Clinical Development, Sanofi, Chilly-Mazarin, France., Laws E; Immunology and Inflammation Global Development, Sanofi, Bridgewater, NJ, USA., Ruddy M; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Praestgaard A; Department of Biostatistics, Sanofi, Cambridge, MA, USA., Amin N; Clinical Sciences Global Development, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Mannent LP; Global Clinical Development, Sanofi, Chilly-Mazarin, France. |
| Source: | The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2023 Dec; Vol. 132 (12), pp. 1649-1661. Date of Electronic Publication: 2023 Jun 15. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 0407300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-572X (Electronic) Linking ISSN: 00034894 NLM ISO Abbreviation: Ann Otol Rhinol Laryngol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1943-572X |
|---|---|
| DOI: | 10.1177/00034894231176334 |
